Abstract
Currently, there is no stable and flexible method to label and track cytotoxic T lymphocytes (CTLs) in vivo in CTL immunotherapy. We aimed to evaluate whether the sulfo-hydroxysuccinimide (NHS)-biotin–streptavidin (SA) platform could chemically modify the cell surface of CTLs for in vivo tracking. CD8+ T lymphocytes were labeled with sulfo-NHS-biotin under different conditions and then incubated with SA–Alexa647. Labeling efficiency was proportional to sulfo-NHS-biotin concentration. CD8+ T lymphocytes could be labeled with higher efficiency with sulfo-NHS-biotin in DPBS than in RPMI (P < 0.05). Incubation temperature was not a key factor. CTLs maintained sufficient labeling for at least 72 h (P < 0.05), without altering cell viability. After co-culturing labeled CTLs with mouse glioma stem cells (GSCs) engineered to present biotin on their surface, targeting CTLs could specifically target biotin-presenting GSCs and inhibited cell proliferation (P < 0.01) and tumor spheres formation. In a biotin-presenting GSC brain tumor model, targeting CTLs could be detected in biotin-presenting gliomas in mouse brains but not in the non-tumor-bearing contralateral hemispheres (P < 0.05). In vivo fluorescent molecular tomography imaging in a subcutaneous U87 mouse model confirmed that targeting CTLs homed in on the biotin-presenting U87 tumors but not the control U87 tumors. PET imaging with 89Zr-deferoxamine-biotin and SA showed a rapid clearance of the PET signal over 24 h in the control tumor, while only minimally decreased in the targeted tumor. Thus, sulfo-NHS-biotin–SA labeling is an efficient method to noninvasively track the migration of adoptive transferred CTLs and does not alter CTL viability or interfere with CTL-mediated cytotoxic activity.
Similar content being viewed by others
Abbreviations
- BAP-TM:
-
Biotin acceptor peptide-transmembrane
- BLI:
-
Bioluminescence imaging
- CT:
-
Computed tomography
- CTL:
-
Cytotoxic T lymphocyte
- DPBS:
-
Dulbecco’s phosphate-buffered saline
- FMT:
-
Fluorescent molecular tomography
- Gluc:
-
Gaussia luciferase
- GSC:
-
Glioma stem cell
- HPLC:
-
High-performance liquid chromatography
- IGFP:
-
Inverted green fluorescent protein
- IVM:
-
Intravital microscopy
- LCMS:
-
Liquid chromatography mass spectroscopy
- NHS:
-
N-hydroxysuccinimide
- NIR:
-
Near infrared
- PET:
-
Positron emission tomography
- SA:
-
Streptavidin
- SEM:
-
Standard error of measurement
- TLC:
-
Thin liquid chromatography
- Zr:
-
Zirconium
References
Rosenberg SA, Restifo NP (2015) Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348(6230):62–68. doi:10.1126/science.aaa4967
de Aquino MT, Malhotra A, Mishra MK, Shanker A (2015) Challenges and future perspectives of T cell immunotherapy in cancer. Immunol Lett 166(2):117–133. doi:10.1016/j.imlet.2015.05.018
Vigneron N (2015) Human tumor antigens and cancer immunotherapy. Biomed Res Int 2015:948501. doi:10.1155/2015/948501
Shapiro EM, Medford-Davis LN, Fahmy TM, Dunbar CE, Koretsky AP (2007) Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. Contrast Media Mol Imaging 2(3):147–153. doi:10.1002/cmmi.134
Lazovic J, Jensen MC, Ferkassian E, Aguilar B, Raubitschek A, Jacobs RE (2008) Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme. Clin Cancer Res 14(12):3832–3839. doi:10.1158/1078-0432.CCR-07-5067
Arbab AS, Janic B, Jafari-Khouzani K, Iskander AS, Kumar S, Varma NR, Knight RA, Soltanian-Zadeh H, Brown SL, Frank JA (2010) Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI. PLoS ONE 5(2):e9365. doi:10.1371/journal.pone.0009365
Pittet MJ, Grimm J, Berger CR, Tamura T, Wojtkiewicz G, Nahrendorf M, Romero P, Swirski FK, Weissleder R (2007) In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci USA 104(30):12457–12461. doi:10.1073/pnas.0704460104
Doubrovin MM, Doubrovina ES, Zanzonico P, Sadelain M, Larson SM, O’Reilly RJ (2007) In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Res 67(24):11959–11969. doi:10.1158/0008-5472.CAN-07-1250
Shu CJ, Radu CG, Shelly SM, Vo DD, Prins R, Ribas A, Phelps ME, Witte ON (2009) Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen. Int Immunol 21(2):155–165. doi:10.1093/intimm/dxn133
Charo J, Perez C, Buschow C, Jukica A, Czeh M, Blankenstein T (2011) Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors. Eur J Immunol 41(11):3187–3197. doi:10.1002/eji.201141452
Du X, Wang X, Ning N, Xia S, Liu J, Liang W, Sun H, Xu Y (2012) Dynamic tracing of immune cells in an orthotopic gastric carcinoma mouse model using near-infrared fluorescence live imaging. Exp Ther Med 4(2):221–225. doi:10.3892/etm.2012.579
Ntziachristos V, Ripoll J, Wang LV, Weissleder R (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 23(3):313–320. doi:10.1038/nbt1074
Whitley MJ, Weissleder R, Kirsch DG (2015) Tailoring adjuvant radiation therapy by intraoperative imaging to detect residual cancer. Semin Radiat Oncol 25(4):313–321. doi:10.1016/j.semradonc.2015.05.005
Schols RM, Connell NJ, Stassen LP (2015) Near-infrared fluorescence imaging for real-time intraoperative anatomical guidance in minimally invasive surgery: a systematic review of the literature. World J Surg 39(5):1069–1079. doi:10.1007/s00268-014-2911-6
Ballou B, Ernst LA, Waggoner AS (2005) Fluorescence imaging of tumors in vivo. Curr Med Chem 12(7):795–805
Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7(5):626–634
Swirski FK, Berger CR, Figueiredo JL, Mempel TR, von Andrian UH, Pittet MJ, Weissleder R (2007) A near-infrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses. PLoS ONE 2(10):e1075. doi:10.1371/journal.pone.0001075
Wang W, Ke S, Wu Q, Charnsangavej C, Gurfinkel M, Gelovani JG, Abbruzzese JL, Sevick-Muraca EM, Li C (2004) Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts. Mol Imaging 3(4):343–351. doi:10.1162/1535350042973481
Houston JP, Ke S, Wang W, Li C, Sevick-Muraca EM (2005) Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Opt 10(5):054010. doi:10.1117/1.2114748
Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63(22):7870–7875
Gottschalk S, Edwards OL, Sili U, Huls MH, Goltsova T, Davis AR, Heslop HE, Rooney CM (2003) Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies. Blood 101(5):1905–1912. doi:10.1182/blood-2002-05-1514
Kwon S, Ke S, Houston JP, Wang W, Wu Q, Li C, Sevick-Muraca EM (2005) Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to alpha v beta 3 receptor expressed in Kaposi’s sarcoma. Mol Imaging 4(2):75–87
Zhang W, Fulci G, Wakimoto H, Cheema TA, Buhrman JS, Jeyaretna DS, Stemmer Rachamimov AO, Rabkin SD, Martuza RL (2013) Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models. Neoplasia 15(6):591–599
Tannous BA, Grimm J, Perry KF, Chen JW, Weissleder R, Breakefield XO (2006) Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat Methods 3(5):391–396. doi:10.1038/nmeth875
Niers JM, Chen JW, Weissleder R, Tannous BA (2011) Enhanced in vivo imaging of metabolically biotinylated cell surface reporters. Anal Chem 83(3):994–999. doi:10.1021/ac102758m
Chung E, Yamashita H, Au P, Tannous BA, Fukumura D, Jain RK (2009) Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS ONE 4(12):e8316. doi:10.1371/journal.pone.0008316
Foster AE, Kwon S, Ke S, Lu A, Eldin K, Sevick-Muraca E, Rooney CM (2008) In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye. Appl Opt 47(31):5944–5952
Youniss FM, Sundaresan G, Graham LJ, Wang L, Berry CR, Dewkar GK, Jose P, Bear HD, Zweit J (2014) Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling. PLoS ONE 9(10):e109162. doi:10.1371/journal.pone.0109162
Acknowledgments
This work was supported by the US National Institute of Health (R01-NS070835 and R01-NS072167), National Natural Science Foundation of China (Grant 81271633). We thank the Memorial Sloan Kettering Cancer Center for providing [89Zr]Zr-oxalate.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Anning Li and Yue Wu have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Li, A., Wu, Y., Linnoila, J. et al. Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models. Cancer Immunol Immunother 65, 1545–1554 (2016). https://doi.org/10.1007/s00262-016-1911-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-016-1911-9